Aethlon Medical (NASDAQ:AEMD) Now Covered by Analysts at StockNews.com

StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Wednesday. The firm issued a sell rating on the medical equipment provider’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a research report on Friday, November 15th.

Aethlon Medical Stock Performance

AEMD stock opened at $0.66 on Wednesday. Aethlon Medical has a 52-week low of $0.24 and a 52-week high of $2.35. The business has a 50-day simple moving average of $0.39 and a two-hundred day simple moving average of $0.42. The company has a market capitalization of $9.22 million, a P/E ratio of -0.23 and a beta of 1.79.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.